Strides Arcolab gets USFDA approval for Buspirone Hydrochloride Tablets

26 Aug 2014 Evaluate

Strides Arcolab has received approval from the United States Food & Drug Administration (USFDA) for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg. Buspirone Tablets are used for the treatment of anxiety disorders and the short-term relief of the symptoms of anxiety.

The US market for generic Buspirone Tablets is around $65 million. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

792.60 -3.60 (-0.45%)
27-Jan-2026 12:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.80
Dr. Reddys Lab 1240.70
Cipla 1309.80
Zydus Lifesciences 889.80
Lupin 2141.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×